Justin Walsh
Stock Analyst at B. Riley Securities
(1.91)
# 3,056
Out of 4,876 analysts
39
Total ratings
38.89%
Success rate
-7.58%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintains: Buy | $122 → $109 | $81.49 | +33.76% | 9 | Jun 23, 2025 | |
| VNRX VolitionRx | Initiates: Buy | $3 | $0.84 | +258.12% | 1 | Jun 10, 2025 | |
| BLRX BioLineRx | Upgrades: Buy | $12 | $4.43 | +170.88% | 3 | May 30, 2025 | |
| CLNN Clene | Initiates: Buy | $30 | $3.76 | +697.87% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $33.60 | - | 1 | Apr 2, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $6.17 | +78.28% | 1 | Mar 11, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $18 | $2.31 | +679.22% | 1 | Dec 16, 2024 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $42 | $11.43 | +267.45% | 1 | Oct 18, 2024 | |
| THTX Theratechnologies | Downgrades: Hold | n/a | $2.37 | - | 2 | Oct 11, 2024 | |
| YMAB Y-mAbs Therapeutics | Initiates: Buy | $23 | $4.70 | +389.36% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $3.76 | +485.11% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.32 | +200.75% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.23 | +796.86% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $1.23 | +225.20% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.42 | +726.45% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $1.06 | +1,598.11% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $440 | $1.38 | +31,784.06% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.32 | +23,701.97% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $30.88 | -35.23% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $2.17 | +9,116.59% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.56 | +290.63% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $800 | $5.54 | +14,340.43% | 1 | Sep 2, 2021 |
Lantheus Holdings
Jun 23, 2025
Maintains: Buy
Price Target: $122 → $109
Current: $81.49
Upside: +33.76%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $0.84
Upside: +258.12%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $4.43
Upside: +170.88%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $3.76
Upside: +697.87%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $33.60
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $6.17
Upside: +78.28%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $2.31
Upside: +679.22%
Rapport Therapeutics
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $11.43
Upside: +267.45%
Theratechnologies
Oct 11, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.37
Upside: -
Y-mAbs Therapeutics
Jul 11, 2024
Initiates: Buy
Price Target: $23
Current: $4.70
Upside: +389.36%
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $3.76
Upside: +485.11%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $5.32
Upside: +200.75%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $2.23
Upside: +796.86%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $1.23
Upside: +225.20%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $2.42
Upside: +726.45%
May 16, 2023
Initiates: Buy
Price Target: $18
Current: $1.06
Upside: +1,598.11%
Feb 10, 2023
Initiates: Buy
Price Target: $440
Current: $1.38
Upside: +31,784.06%
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $0.32
Upside: +23,701.97%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $30.88
Upside: -35.23%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $2.17
Upside: +9,116.59%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $2.56
Upside: +290.63%
Sep 2, 2021
Initiates: Buy
Price Target: $800
Current: $5.54
Upside: +14,340.43%